PacificoBiolabs Raises $7.6M Series A to Turn Brewery Infrastructure Into Protein Production

Why It Matters

By turning under‑utilized brewery assets into protein factories, Pacifico creates a cost‑effective, sustainable supply chain that could reduce Europe’s reliance on imported feed protein and accelerate price parity with conventional meat.

Key Takeaways

• €7M Series A (~$7.6M) funding secured.
• Uses beer brewery tanks instead of costly bioreactors.
• Targets under‑utilized European brewery capacity.
• Aims for domestic protein to cut import reliance.
• Plans DACH and Nordic retail launch by late 2026.

Pulse Analysis

The alternative‑protein sector has long grappled with the capital intensity of fermentation facilities. Traditional mycelium producers invest heavily in custom bioreactors, inflating unit costs and slowing market entry. PacificoBiolabs sidesteps this hurdle by adapting standard brewery fermentation tanks, a proven, scalable platform that already exists across Europe. This asset‑light model not only trims upfront expenditures but also shortens the timeline to commercial production, positioning the company to meet rising demand for plant‑based protein ingredients.

Europe’s brewing industry is confronting a steady decline in beer and alcohol consumption, leaving large fermentation capacities idle. Pacifico’s strategy turns this surplus into an opportunity, repurposing the tanks to generate protein locally. The move aligns with broader sustainability goals, as domestically produced mycelium protein reduces the carbon footprint associated with importing soy or other feed proteins. Moreover, it mitigates geopolitical risks tied to external supply chains, offering a resilient source of nutrition for the region’s growing meat‑alternative market.

The €7 million Series A injection signals investor confidence in this hybrid approach, highlighting a potential pathway to price parity with conventional meat. As Pacifico scales operations in Saxony and expands into the DACH and Nordic markets, it could set a precedent for other food‑tech firms to leverage existing industrial infrastructure. If successful, the model may catalyze a wave of similar conversions, accelerating the transition toward a more sustainable, locally sourced protein ecosystem across Europe.

Deal Summary

PacificoBiolabs, a mycelium‑fermentation protein startup, announced a €7 million ($7.6 million) Series A round backed by Stray Dog Capital, TGFS, Sprout & About Ventures, Simon Capital, FoodLabs and a regional brewery partner. The funding will be used to scale production in Saxony, expand the team, and launch commercial products across the DACH region and Nordic Europe by late 2026. The company leverages existing brewery fermentation tanks to produce protein ingredients, aiming to lower costs and reduce reliance on imported feed protein.